Chemical Structure (Image 01)
Fosaprepitant Dimeglumine Injection, Powder, Lyophilized, For Solution
Product Images NDC 67184-0540
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant Dimeglumine (NDC 67184-0540). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (150 mg Vial Label)
This is a product description for a pharmaceutical drug called "Fosaprepitant" manufactured by Qi Pharmaceutical Company in China. The drug comes in a sterile lyophilized form with 150 mg per vial and is intended for intravenous use only. It needs to be stored refrigerated and has a dosage of 150 mg. The text also includes some specific codes and details such as NDC, Rxonly, and GTIN.*
Principal Display Panel (150 mg Carton Label)
Fosaprepitant for Injection is a medication containing 150mg per vial. It is recommended to be used with caution as it may cause serious side effects. This medication should be stored at room temperature and should not be used with solutions containing divalent ions. The recommended dosage is 150mg per vial and unused portions should be discarded. Overall, Fosaprepitant is a prescription drug that requires careful handling and administration.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
